Arcutis Biotherapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Arcutis Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Arcutis Biotherapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Arcutis Biotherapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $231k | 72k | 3.23 |
| 2023-09-30 | $418k | 79k | 5.31 |
| 2023-06-30 | $677k | 71k | 9.53 |
| 2023-03-31 | $605k | 55k | 10.99 |
| 2022-12-31 | $660k | 45k | 14.80 |
| 2022-06-30 | $707k | 33k | 21.34 |
| 2022-03-31 | $519k | 27k | 19.21 |
| 2021-12-31 | $466k | 22k | 20.82 |
| 2021-03-31 | $430k | 15k | 28.94 |
| 2020-12-31 | $239k | 9.3k | 25.64 |
| 2020-09-30 | $209k | 6.7k | 31.01 |
| 2020-06-30 | $96k | 3.2k | 30.11 |
| 2020-03-31 | $100k | 3.4k | 29.84 |